Gaby [Analyst]'s questions to DocGo Inc (DCGO) leadership • Q3 2024
Question
Gaby, on behalf of Sarah, inquired about the drivers for the Q3 EBITDA outperformance and asked about potential expense pressures from the expansion of the care gap closure business.
Answer
CFO Norman Rosenberg attributed the strong EBITDA beat primarily to higher-than-expected gross margins of 36%, driven by a favorable project mix and controlled SG&A. CEO Lee Bienstock added that investments for the rapid expansion of payer programs are reflected in the 2025 EBITDA guidance.